Cefoperazone/Sulbactam + Co-trimoxazole vs Ceftazidime + Co-trimoxazole in the Treatment of Severe Melioidosis: A Randomized, Double-Blind, Controlled Study

Journal of the Medical Association of Thailand

Volumn 81, Issue 4, 1998, Pages 265-271

  Thamprajamchit, Sriurai ^a   Chetchotisakd, Ploenchan ^a   Thinkhamrop, Bandit ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; SULPERAZON;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MELIOIDOSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SEPTICEMIA; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEFOPERAZONE; CEFTAZIDIME; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MELIOIDOSIS; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SULBACTAM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0031816292     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Punyagupta S. Melioidosis : review of 686 cases and presentation of a new clinical classification. In : Punyagupta S, Sirisanthana T, Stapatayawong B, eds. Melioidosis. Bangkok : Bangkok Medical Publisher, 1989: 217-29.
2. Chaowagul W, White NJ, Dance DAB, et al. Melioidosis : A major cause of community-acquired septicemia in North Eastern Thailand. J infect Dis 1989; 159: 890-9.
3. Sookpranee M, Boonma P, Bhuripanyo K, et al. Melioidosis at Srinagarind Hospital. In : Punyagupta S, Sirisanthana T, Stapatayawong B, eds. Melioidosis. Bangkok, Bangkok Medical Publisher, 1989: 34-47.
4. Sookpranee M, Boonma P, Susaengrat W, et al. Multicenter prospective randomized trial comparing ceftazidime plus cotrimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother 1992; 36: 159-62.
5. White NJ, Dance DAB, Chaowagul W, et al. Having of mortality of severe melioidosis by ceftazidime. Lancet 1989; 2: 697-701.
6. Dance DAB, Wuthiekanon V, Chaowagul W, et al. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J Antimicrob Chemother 1991; 28: 321-34.
7. Sookpranee T, Sookpranee M, Mellencamp MA, et al. Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to bactericidal effects of many antibiotics. Antimicrob Agents Chemother 1991; 35: 484-9.
8. Puthucheary SD, Parasakthi N, Antimicrobial susceptibility of Pseudomonas psuedomallei. J Antimicrob Chemother 1987; 20: 921-2.
9. Chau PY, Ng WS, Leung YK, Lolekha S. In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer ß-lactam antibiotics & quinolone derivatives. J Infect Dis 1986; 153 : 167-70.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
11. Suputtamongkol Y, Rajchanuwong A, Chaowagul W, et al. Ceftazidime vs amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 1994; 19: 846-53.